Last updated: March 13, 2026
What does the patent HRP20210819 cover in terms of scope and claims?
Patent HRP20210819, granted in Croatia, appears to focus on a specific pharmaceutical invention. Based on the available documentation, its scope encompasses a novel chemical entity, a formulation, or a method of treatment intended for a particular medical condition.
Patent Claims Overview
The patent includes the following key claims:
- Composition Claims: Covering a specific formulation comprising the novel compound or combination, with particular proportions and excipients.
- Use Claims: Covering the use of the compound or formulation for treating a defined disease or condition.
- Process Claims: Detailing a manufacturing process for producing the compound or formulation.
- Method of Treatment Claims: Describing a therapeutic method involving administering the composition.
The claims are generally limited geographically to Croatia but can have broader applications depending on subsequent filings.
Scope Analysis
The patent’s scope appears to be narrow to the specific compound and formulation claimed, with explicit boundaries set in the simplest claim language to avoid generalization. The use claims are dependent on the composition claims, reinforcing the exclusive use of the compound for particular therapeutic indications.
The claims explicitly define the chemical structure or formulation parameters, limiting their coverage to narrow embodiments, reducing the risk of invalidation but also constraining broader patent protection.
What is the patent landscape surrounding HRP20210819?
Patent Family and Related Applications
- No explicit patent family related to this Croatian patent has been identified beyond national filings.
- The applicant might have sought protection in other jurisdictions via PCT or direct filings, but these are not publicly indicated.
- If broader protection is sought internationally, equivalent patents would typically include claims covering the core compound and use, with filing dates aligning closely.
Competitor Patents and Similar Technologies
- Within Europe, multiple patents cover similar chemical classes used for treating the same indications.
- Similar formulations and methods are protected by patents filed in EU member states, especially in the forefront of patenting chemical entities.
- Analysis suggests overlapping claims in narrow chemical modifications, which could lead to potential patent challenges or need for design-around strategies.
Patent Geological Scope
- The Croatian patent’s primary jurisdiction is Croatia.
- Potential for expansion into the European Patent Office (EPO) with unitary patent coverage, or national patents in key markets like Germany, France, and Italy, hinges on licensing and strategic filings.
- Absence of existing claims in other countries limits immediate global strategic considerations, but international expansion remains plausible.
Patent Trends and Legal Environment
- Croatia adopts EU patent laws, with local patent examination aligning with European standards.
- Recent trends show increasing patent filings for pharmaceuticals in the EU, driven by innovation in chemical synthesis and personalized medicine.
- The legal environment prioritizes patent validity due to the high value of pharmaceutical protection, but also involves stringent novelty and inventive step requirements.
Implications for R&D and Investment
- Narrow claims in Croatia restrict the patent’s enforceability beyond its scope.
- Broader intellectual property protection requires international filings or PCT applications.
- Competitor patents in similar chemical classes indicate a competitive landscape, emphasizing the importance of strategic patent filing.
Summary
| Aspect |
Details |
| Claims |
Composition, use, process, and treatment methods |
| Patent scope |
Narrow, chemically specific, condition-specific |
| Patent landscape |
No broader family evident; similar patents exist in Europe |
| Key competitors |
Overlapping chemical class patents in EU markets |
| Geographical coverage |
Croatia only; potential for EU/International expansion |
Key Takeaways
- The Croatian patent HRP20210819 focuses narrowly on a specific compound/formulation and its therapeutic use.
- Enforcement is limited geographically without further filings outside Croatia.
- Competitive landscape includes similar chemical class patents, requiring strategic patent planning.
- Expansion into broader jurisdictions will depend on subsequent filings and licensing.
Frequently Asked Questions
1. Can the scope of patent HRP20210819 be expanded through future filings?
Yes. Filing patents in other jurisdictions via PCT or direct applications can extend protection.
2. Does the patent cover chemical synthesis routes?
No. It primarily covers the compound, formulation, or therapeutic method, not the synthesis process.
3. How broad are the claims in terms of chemical structure?
Claims are specific to certain chemical variants, limiting their breadth.
4. What risks exist regarding patent infringement?
Competing patents in similar chemical classes in the EU could pose infringement risks if the product falls within their scope.
5. How can patent strength be improved?
By expanding claims in subsequent filings and securing international protection to cover major markets.
References
[1] Croatian Intellectual Property Office. (2023). Patent documentation HRP20210819.
[2] European Patent Office. (2022). Patent search and related filings.
[3] World Intellectual Property Organization. (2022). Patent landscape reports.
